Joseph Todisco

CEO

Chairman

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

CorMedix Inc. (CRMD)
Chairman

SEC 8-K

Current
2026-01-08–present
CorMedix Inc. (CRMD)
Board Member

Proxy statement

Current
2022-01-01–present
CorMedix Inc. (CRMD)
CEO

Proxy statement

Current
Amneal Pharmaceuticals, Inc. (AMRX)
Proxy statement

Start not stated–2022-03-15

Recorded roles and earnings-call appearances connecting this person to public companies.

CRMD

Current role

CEO, Chairman, Board Member

2022-01-01–present

7 calls Latest call 2026-05-14

AMRX

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	CorMedix Inc. (CRMD)	Chief Executive Officer	$684,353	—	$4,492,500	—	$865,072	$59,251	$6,101,176
2024	CorMedix Inc. (CRMD)	Chief Executive Officer	$639,214	—	$462,666	$745,788	$457,335	$54,906	$2,359,908
2023	CorMedix Inc. (CRMD)	Chief Executive Officer	$616,962	—	—	$1,388,400	$401,700	$52,370	$2,459,342
2022	CorMedix Inc. (CRMD)	Chief Executive Officer	$378,461	—	$701,245	$1,273,500	$305,760	$32,223	$2,691,189
2021	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Specialty	$523,615	—	$1,298,557	—	$318,150	$16,287	$2,156,610
2020	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Specialty	$458,539	—	$881,006	—	$315,153	$16,431	$1,671,129

Earnings-call appearances and filed executive appointments or departures, newest first.